Switching to deltoid intramuscular injections maintains therapeutic trough concentrations of rilpivirine and cabotegravir in people with HIV

被引：1
|
作者：
Cossu, Maria Vittoria [1 ]
D'Avolio, Antonio [2 ]
Gervasoni, Cristina [1 ]
Giacomelli, Andrea [1 ]
Cattaneo, Dario [1 ]
Moschese, Davide [1 ]
机构：
[1] ASST Fatebenefratelli Sacco Univ Hosp, Dept Infect Dis, Milan, Italy
[2] Univ Turin, Amedeo Savoia Hosp, Dept Med Sci, Lab Clin Pharmacol & Pharmacogenet, Turin, Italy
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2024年 / 68卷 / 05期
关键词：
human immunodeficiency virus; PHARMACOKINETICS; TOLERABILITY; GSK1265744; ADULTS; SAFETY;
D O I：
10.1128/aac.00175-24
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Background factors in people living with HIV in Japan who switch to cabotegravir plus rilpivirine: A pilot study
    Adachi, Eisuke
    Ikeuchi, Kazuhiko
    Koga, Michiko
    Yotsuyanagi, Hiroshi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2023, 29 (01) : 109 - 111
  • [22] Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Michael G. Sension
    Laurence Brunet
    Ricky K. Hsu
    Jennifer S. Fusco
    Quateka Cochran
    Christine Uranaka
    Gayathri Sridhar
    Vani Vannappagari
    Jean Van Wyk
    Lewis McCurdy
    Michael B. Wohlfeiler
    Gregory P. Fusco
    Infectious Diseases and Therapy, 2023, 12 : 2807 - 2817
  • [23] Single-center experience evaluating and initiating people with HIV on long-acting cabotegravir/rilpivirine
    Hill, Lucas A.
    Abulhosn, Kari K.
    Yin, Jeffrey F.
    Bamford, Laura P.
    AIDS, 2023, 37 (04) : 605 - 609
  • [24] Therapeutic review of cabotegravir/rilpivirine long-acting antiretroviral injectable and implementation considerations at an HIV specialty clinic
    Howe, Zach W.
    Norman, Sarah
    Lueken, Abbie F.
    Huesgen, Emily
    Farmer, Eric K.
    Jarrell, Kaitlyn
    Mathis, Joscelyn E.
    Bonham, Kyle W.
    Hahn, Julie
    PHARMACOTHERAPY, 2021, 41 (08): : 686 - 699
  • [25] Cabotegravir plus Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort
    Sension, Michael G.
    Brunet, Laurence
    Hsu, Ricky K.
    Fusco, Jennifer S.
    Cochran, Quateka
    Uranaka, Christine
    Sridhar, Gayathri
    Vannappagari, Vani
    Van Wyk, Jean
    Mccurdy, Lewis
    Wohlfeiler, Michael B.
    Fusco, Gregory P.
    INFECTIOUS DISEASES AND THERAPY, 2023, 12 (12) : 2709 - 2724
  • [26] Evaluating cabotegravir/rilpivirine long-acting, injectable in the treatment of HIV infection: emerging data and therapeutic potential
    Fernandez, Cristina
    van Halsema, Clare L.
    HIV AIDS-RESEARCH AND PALLIATIVE CARE, 2019, 11 : 179 - 192
  • [27] Subcutaneous injections of cabotegravir plus rilpivirine in virally suppressed adults with HIV-1: a substudy of the Phase 3 FLAIR study
    D'Amico, R.
    Han, K.
    Min, S.
    DeMoor, R.
    St Clair, M.
    Ford, S. L.
    Harrington, C.
    Bernal Morell, E.
    Lombaard, J.
    Crauwels, H.
    Kolobova, I.
    Patel, N.
    Jamil, N.
    Van Solingen-Ristea, R.
    Acuipil, C.
    Spreen, W.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 18 - 18
  • [28] HIV viremias among patients who discontinued Cabotegravir (CAB)/Rilpivirine (RPV) Long acting (LA) intramuscular (IM) in reallife setting
    Seang, S.
    Palacios, C.
    Valin, N.
    Gansou, A.
    Faycal, A.
    Vincensini, J-P
    Abdi, B.
    Lambert-Niclot, S.
    Peytavin, G.
    Katlama, C.
    Pialoux, G.
    Lacombe, K.
    Pourcher, V.
    Valantin, M-A
    HIV MEDICINE, 2023, 24 : 150 - 151
  • [29] The propensity for long-acting cabotegravir and rilpivirine every 2 months among HIV-infected people eligible for treatment
    Alberton, Francesca
    Nozza, Silvia
    Raccagni, Angelo Roberto
    Galli, Laura
    Spagnuolo, Vincenzo
    Bossolasco, Simona
    Cernuschi, Massimo
    Canetti, Diana
    Hasson, Hamid
    Castagna, Antonella
    Gianotti, Nicola
    JOURNAL OF MEDICAL VIROLOGY, 2023, 95 (01)
  • [30] Willingness to Switch to Long-Acting Injectable Cabotegravir and Rilpivirine Every 2 Months for People Living with HIV in Nanjing, China
    Li, Mengqing
    Guan, Hongjing
    Zhong, Mingli
    Di, Xiaoyun
    Yu, Nawei
    Chen, Chen
    Cai, Rentian
    Wei, Hongxia
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2025, 41 (02) : 107 - 112
12345